Volume 30, Number 7—July 2024
Research
Newly Recognized Spotted Fever Group Rickettsia as Cause of Severe Rocky Mountain Spotted Fever–Like Illness, Northern California, USA
Table 1
Feature | Case-patient 1 | Case-patient 2 |
---|---|---|
Clinical | ||
Fever at hospital admission | Present, 103°F (39.4°C) | Present, 101.8°F (38.8°C) |
Inoculation eschar | Absent | Absent |
Rash | Absent | Present, maculopapular including palms |
Myalgia | Present | Present |
Headache | Present | Present |
Nausea | Present | Present |
Vomiting | Present | Present |
Diarrhea | Present | Absent |
Abdominal pain | Present | Absent |
Acute kidney injury | Present | Absent |
Photophobia | Present | Present |
Altered mental status | Present | Present |
Acute respiratory failure | Present | Present |
Cutaneous necrosis and gangrene | Present | Absent |
Coma | Present | Present |
Days in intensive care unit | 11 | 4 |
Days hospitalized |
22 |
13 |
Laboratory† | ||
Serum sodium | Low (124 mEq/L) | Low (133 mEq/L) |
Serum lactate dehydrogenase | High (421 U/L) | High (1,280 U/L) |
Serum creatinine | High (1.44 mg/dL) | Unremarkable (1.0 mg/dL) |
Serum bilirubin, total | High (2.3 mg/dL) | Unremarkable (0.6 mg/dL) |
Aspartate transaminase | High (483 U/L) | High (268 U/L) |
Alanine transaminase | High (323 U/L) | High (125 U/L) |
CBC platelets | Low (45K/uL) | Low (80K/uL) |
CBC leukocyte count | Unremarkable (4.5K/uL) | High (12.9K/uL) |
CBC neutrophil percentage | Unremarkable (64%) | High (84%) |
CSF glucose | NA | Unremarkable (69 mg/uL) |
CSF protein | NA | High (147 mg/dL) |
CSF leukocyte count | NA | High (9/uL) |
SFG Rickettsia IgG titer (acute) | Unremarkable <1:128 | Elevated (1:4,096) |
SFG Rickettsia IgG titer (convalescent) | Elevated (>1:256) | Elevated (1:16,384) |
*CBC, complete blood count; CSF, cerebral spinal fluid; NA, not applicable; RMSF, Rocky Mountain spotted fever; SFG, spotted fever group. †Samples for the blood metabolic panel, CBC, and CSF analyses (case-patient 2 only) were collected on the day of hospital admission for case-patient 1 and 3 days after hospital admission for case-patient 2.
Page created: May 17, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.